Stanislav Glezer is the Managing Director at Outcome Capital, based in the United States. He assumed this role in May 2024.
Concurrently, he serves as a Professional Member on the Board of Advisors for the College of Business and Public Management at Kean University.
Prior to his current positions, Stanislav held various executive roles, including EVP R&D and Chief Medical Officer at Inogen, and WorldWide VP, Medical Affairs & Business Development, Diabetes Care at BD.
He has also served in leadership roles at Sanofi, Novo Nordisk, and ADOCIA, among others.
Stanislav's extensive experience spans across medical affairs, business development, and regulatory affairs in the pharmaceutical and biotech industries.